ULTRATECH CEMENT: Below estimates; revival of CTIL’s plants to remain key

ULTRATECH CEMENT: Below estimates; revival of CTIL’s plants to remain key

–       Volumes decline, realizations decrease sequentially: 2QFY20 consolidated volumes (including white cement) declined 1% YoY to 18.7mt. Realizations decreased 3% QoQ due to weaker prices in the southern and eastern regions of India. Net sales grew 4% YoY to INR96b. Cost/t declined 1% YoY to INR 4,121/t. Thus, EBITDA/t rose 36% YoY to INR1,026/t (-25% QoQ). While EBITDA grew 35% YoY to INR19b, margin expanded 4.6pp YoY to 19.9%. PAT stood at INR5.8b (+62% YoY).

–       Ex Century, EBITDA in line: Excluding Century, volumes increased 3% YoY (in-line). Realizations increased 5% YoY (-3% QoQ) to INR5,163 and net sales grew 7% YoY to INR88.6b (in-line). Cost/t declined 3% YoY but increased 3% QoQ due to higher other expenses/t. EBITDA/t increased 42% YoY (down 22% QoQ) to INR 1,132/t (below est. of INR1,188/t due to higher other expenses). EBITDA stood at INR19.2b (v/s est. of INR20b).

–       Management commentary: (1) All India demand reduced by 2-2.5% YoY in 2QFY20 led by 3-4% decline in the South/East. (2) The board has approved 3.4mt capacity expansion in the East through two brownfield expansions (Patliputra in Bihar and Dankuni in West Bengal) and a greenfield grinding unit in Odisha. (3) Century’s cement assets operated at 48% utilization in 2QFY20 and generated nil EBITDA (INR60/t incl. other income). Utilization for 2QFY19 stood at 64% with EBITDA/t of INR500/t. The reduction in utilization was due to maintenance shutdown taken for the plants in 2QFY20. (4) Net debt reduced by INR15b over Mar-Sep’19.

–       Strong 1HFY20 performance: Revenue/EBITDA/PAT were up 12%/52%/97% YoY to INR210b/INR48.7b/INR18.6b in 1HFY20. We expect revenue/EBITDA/PAT to increase 18%/38%/42% in 2HFY20.

–       Enhanced pricing power aided by aggressive capacity growth: Driven by an inorganic growth strategy, UTCEM expanded its capacity by 65% since FY17 to 109.4mt (23% of all-India capacity). We believe that this has provided it significant pricing power, particularly in Central/West India where it now has ~40% market share. We forecast EBITDA to report 30% CAGR and EPS to show 42% CAGR in FY19-21E, driven by 14% CAGR in volume and better margins. The company trades at 13.8x/12x EV on FY20/FY21 EBITDA. We value UTCEM at 14x FY21 EV/EBITDA and arrive at a target price of INR4,950 (implied EV/t of USD180/t on FY21 capacity). Maintain Buy.

(Report on Ultratech Cement 2QFY20 by Motilal Oswal Institutional Equities)

Comments

Popular posts from this blog

EzyStayz Kicks Off Its First Exchange Listing With Foblgate

ETF Securities offers Australian investors first access to India growth story

Vivo V20 Pro India Launch Confirmed for December 2: Expected Price, Specifications